Olufunmilayo I Olopade Selected Research

Olufunmilayo I Olopade Research Topics

Disease

130	Breast Neoplasms (Breast Cancer) 11/2022 - 03/2002
107	Neoplasms (Cancer) 04/2022 - 03/2002
18	Ovarian Neoplasms (Ovarian Cancer) 04/2017 - 05/2002
11	Triple Negative Breast Neoplasms 01/2021 - 10/2008
7	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2002
6	Carcinogenesis 01/2018 - 04/2008
5	Lymphatic Metastasis 12/2013 - 01/2008
4	Squamous Cell Carcinoma of Head and Neck 12/2015 - 03/2002
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 12/2006
3	Genetic Risk Score 01/2020 - 12/2017
3	Disease Progression 01/2020 - 01/2006
3	Hypoxia (Hypoxemia) 10/2018 - 07/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 12/2006
3	Colonic Neoplasms (Colon Cancer) 07/2012 - 01/2010
3	Carcinoma (Carcinomatosis) 06/2010 - 05/2002
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2016
2	Fallopian Tube Neoplasms 01/2022 - 07/2006
2	Genomic Instability 11/2021 - 06/2012
2	Diarrhea 06/2020 - 09/2008
2	Leukemia 01/2016 - 11/2004
2	Colorectal Neoplasms (Colorectal Cancer) 04/2015 - 10/2012
2	Ductal Carcinoma 04/2012 - 02/2007
2	Head and Neck Neoplasms (Head and Neck Cancer) 07/2010 - 03/2002
2	Aneuploidy (Aneuploid) 07/2007 - 01/2004
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2020
1	Sickle Cell Trait 07/2020
1	Hand-Foot Syndrome 06/2020
1	Noncommunicable Diseases 07/2019

Drug/Important Bio-Agent (IBA)

35	Estrogen ReceptorsIBA 11/2022 - 03/2003
22	Hormones (Hormone)IBA 04/2022 - 03/2002
17	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2003
13	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2012
13	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2006
13	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2006
12	Biological ProductsIBA 01/2018 - 01/2006
10	human ERBB2 proteinIBA 01/2022 - 09/2009
7	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2018
7	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 12/2005
7	Estrogens (Estrogen)FDA Link 12/2017 - 01/2008
6	Messenger RNA (mRNA)IBA 01/2022 - 08/2003
5	MicroRNAs (MicroRNA)IBA 11/2019 - 01/2013
4	NucleotidesIBA 11/2022 - 12/2010
4	ParaffinIBA 01/2022 - 03/2002
4	Contrast MediaIBA 01/2021 - 12/2011
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 03/2009
4	ORALIT (ORS)IBA 04/2018 - 03/2011
4	ErbB Receptors (EGF Receptor)IBA 12/2015 - 01/2010
3	Formaldehyde (Formol)FDA Link 01/2022 - 03/2002
3	Tamoxifen FDA LinkGeneric 01/2020 - 06/2004
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 04/2015
3	Indicators and Reagents (Reagents)IBA 11/2016 - 08/2011
3	CateninsIBA 05/2016 - 07/2013
3	Gefitinib (Iressa)FDA Link 06/2013 - 07/2010
3	Insulin-Like PeptidesIBA 08/2012 - 04/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 11/2019
2	CytokinesIBA 01/2021 - 07/2019
2	Long Noncoding RNAIBA 01/2021 - 10/2018
2	N 30IBA 01/2021 - 01/2014
2	Capecitabine (Xeloda)FDA Link 06/2020 - 09/2013
2	CopperIBA 01/2019 - 02/2007
2	AmberIBA 01/2017 - 01/2017
2	Small Interfering RNA (siRNA)IBA 05/2016 - 01/2015
2	Codon (Codons)IBA 02/2016 - 01/2012
2	Metformin (Glucophage)FDA LinkGeneric 01/2016 - 04/2015
2	Decitabine FDA Link 01/2016 - 12/2006
2	hydrogen sulfite (bisulfite)IBA 01/2016 - 01/2015
2	Pharmaceutical PreparationsIBA 07/2015 - 07/2011
2	Trastuzumab (Herceptin)FDA Link 07/2015 - 04/2013
2	Tumor Biomarkers (Tumor Markers)IBA 12/2013 - 09/2012
2	Histones (Histone)IBA 10/2013 - 01/2008
2	VimentinIBA 01/2013 - 02/2006
2	Interleukin-11 (Interleukin 11)IBA 01/2013 - 01/2013
2	Estrogen Receptor alphaIBA 09/2012 - 09/2008
2	Cyclin D1IBA 09/2009 - 03/2002
2	Dihydrotachysterol (AT 10)IBA 06/2004 - 03/2004
1	Phosphotransferases (Kinase)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Penicillins (Penicillin)FDA Link 07/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2020
1	hemoglobin AAIBA 07/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Volatile Fatty AcidsIBA 10/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2019

Therapy/Procedure

27	Therapeutics 04/2022 - 05/2006
13	Drug Therapy (Chemotherapy) 01/2021 - 12/2008
9	Ovariectomy (Oophorectomy) 01/2022 - 05/2002
9	Salpingo-oophorectomy 06/2015 - 01/2004
4	Radiotherapy 06/2017 - 06/2006
4	Neoadjuvant Therapy 06/2017 - 04/2012
4	Mastectomy (Mammectomy) 11/2014 - 06/2004
3	Complementary Therapies (Alternative Medicine) 01/2020 - 12/2014
2	Chemoprevention 04/2017 - 02/2012
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 09/2013 - 11/2005
2	Chemoradiotherapy 07/2010 - 09/2008
2	Prophylactic Mastectomy 03/2004 - 05/2002
1	Treatment Delay 01/2021
1	Fat-Restricted Diet (Diet, Fat Restricted) 10/2020
1	Institutionalization (Institutionalized Persons) 07/2019